Jul 29 |
Seeking Clues to ResMed (RMD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
Jul 26 |
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
|
Jul 25 |
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
|
Jul 13 |
Eli Lilly’s GLP-1 impact on ResMed is overblown: Barron’s
|
Jul 11 |
GLP-1 Concerns Clobbered This Healthcare Stock. It’s Time to Buy.
|
Jul 8 |
Should You Hold STERIS (STE) Stock Now? Here's What to Consider
|
Jul 3 |
ResMed: Potentially Undervalued Amid Increasing Sleep Apnea Awareness
|
Jul 3 |
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
|
Jul 3 |
Omnicell (OMCL) Banks on Product Launches, Global Growth
|
Jul 3 |
ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
|